In vivo and in vitro evaluation of antibacterial and anti-inflammatory activities of extraction of crude saponin isolated from licorice roots against Streptococcus pneumoniae.

Q2 Pharmacology, Toxicology and Pharmaceutics
Zinah Essam Hameed, Saja Majeed Shareef, Omar Hussein Ahmed
{"title":"<i>In vivo</i> and <i>in vitro</i> evaluation of antibacterial and anti-inflammatory activities of extraction of crude saponin isolated from licorice roots against <i>Streptococcus</i> <i>pneumoniae</i>.","authors":"Zinah Essam Hameed, Saja Majeed Shareef, Omar Hussein Ahmed","doi":"10.1515/dmpt-2025-0042","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Antibiotic resistance is a global health concern, prompting exploration of alternative therapies, including medicinal herbs. <i>Glycyrrhiza glabra</i> (licorice) contains saponins, which may possess antibacterial and antioxidant properties. This study aims to evaluate the antibacterial and antioxidant activities of saponin extracted from <i>G. glabra</i> and assess its safety and immunomodulatory effects <i>in vivo</i>.</p><p><strong>Methods: </strong>Saponin was isolated from licorice roots using a Soxhlet apparatus with 70 % ethanol as the extraction solvent over 168 h. Antioxidant activity of the extract was evaluated using 2,2-diphenyl-1-picrylhydrazyl (DPPH)-free radical scavenging assay and ferric reducing antioxidant power (FRAP) assay. Antibacterial activity toward <i>Streptococcus pneumoniae</i> was detected using broth microdilution method to evaluate minimum inhibitory concentration (MIC). <i>In vivo</i> safety and immunomodulatory effects were assessed in mice.</p><p><strong>Results: </strong>Saponin exhibited an IC<sub>50</sub> of 20.16 ± 0.21 μg/mL in the DPPH assay. Inhibition zones against <i>S. pneumoniae</i> were observed at concentrations of 10 μg/mL (6.4 mm), 20 μg/mL (17.6 mm), and 50 μg/mL (21.9 mm). <i>In vivo</i>, treatment with 20 μg/mL saponin resulted in a 0.06 μg/mL fold increase in IFN-γ levels compared to control without adverse effects on hepatic enzymes, hematological parameters, or histopathology.</p><p><strong>Conclusions: </strong>Saponin from <i>G. glabra</i> demonstrates promising <i>in vitro</i> antioxidant and antibacterial activities against <i>S. pneumoniae</i>, with favorable safety and immunomodulatory profiles <i>in vivo</i>, supporting its potential as a natural therapeutic candidate.</p>","PeriodicalId":11332,"journal":{"name":"Drug metabolism and personalized therapy","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug metabolism and personalized therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1515/dmpt-2025-0042","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: Antibiotic resistance is a global health concern, prompting exploration of alternative therapies, including medicinal herbs. Glycyrrhiza glabra (licorice) contains saponins, which may possess antibacterial and antioxidant properties. This study aims to evaluate the antibacterial and antioxidant activities of saponin extracted from G. glabra and assess its safety and immunomodulatory effects in vivo.

Methods: Saponin was isolated from licorice roots using a Soxhlet apparatus with 70 % ethanol as the extraction solvent over 168 h. Antioxidant activity of the extract was evaluated using 2,2-diphenyl-1-picrylhydrazyl (DPPH)-free radical scavenging assay and ferric reducing antioxidant power (FRAP) assay. Antibacterial activity toward Streptococcus pneumoniae was detected using broth microdilution method to evaluate minimum inhibitory concentration (MIC). In vivo safety and immunomodulatory effects were assessed in mice.

Results: Saponin exhibited an IC50 of 20.16 ± 0.21 μg/mL in the DPPH assay. Inhibition zones against S. pneumoniae were observed at concentrations of 10 μg/mL (6.4 mm), 20 μg/mL (17.6 mm), and 50 μg/mL (21.9 mm). In vivo, treatment with 20 μg/mL saponin resulted in a 0.06 μg/mL fold increase in IFN-γ levels compared to control without adverse effects on hepatic enzymes, hematological parameters, or histopathology.

Conclusions: Saponin from G. glabra demonstrates promising in vitro antioxidant and antibacterial activities against S. pneumoniae, with favorable safety and immunomodulatory profiles in vivo, supporting its potential as a natural therapeutic candidate.

甘草根粗皂苷对肺炎链球菌的体内外抑菌活性评价。
目的:抗生素耐药性是一个全球性的健康问题,促使探索替代疗法,包括草药。甘草含有皂苷,具有抗菌和抗氧化的特性。本研究旨在评价光草皂苷的抗菌和抗氧化活性,并评价其在体内的安全性和免疫调节作用。方法:采用索氏提取装置,提取溶剂为70% %乙醇,提取时间为168 h。采用2,2-二苯基-1-苦味酰肼(DPPH)自由基清除法和铁还原抗氧化能力(FRAP)法评价提取物的抗氧化活性。采用微量肉汤稀释法测定其对肺炎链球菌的抑菌活性,并评价最低抑菌浓度(MIC)。在小鼠中评估了体内安全性和免疫调节作用。结果:皂苷对DPPH的IC50为20.16±0.21 μg/mL。在浓度为10 μg/mL(6.4 mm)、20 μg/mL(17.6 mm)和50 μg/mL(21.9 mm)时,对肺炎链球菌有抑制区。在体内,与对照组相比,20 μg/mL皂素处理导致IFN-γ水平增加0.06 μg/mL,而对肝酶、血液学参数或组织病理学没有不良影响。结论:光天葵皂苷对肺炎链球菌具有良好的体外抗氧化和抗菌活性,在体内具有良好的安全性和免疫调节作用,支持其作为天然治疗候选药物的潜力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Drug metabolism and personalized therapy
Drug metabolism and personalized therapy Pharmacology, Toxicology and Pharmaceutics-Pharmacology, Toxicology and Pharmaceutics (all)
CiteScore
2.30
自引率
0.00%
发文量
35
期刊介绍: Drug Metabolism and Personalized Therapy (DMPT) is a peer-reviewed journal, and is abstracted/indexed in relevant major Abstracting Services. It provides up-to-date research articles, reviews and opinion papers in the wide field of drug metabolism research, covering established, new and potential drugs, environmentally toxic chemicals, the mechanisms by which drugs may interact with each other and with biological systems, and the pharmacological and toxicological consequences of these interactions and drug metabolism and excretion. Topics: drug metabolizing enzymes, pharmacogenetics and pharmacogenomics, biochemical pharmacology, molecular pathology, clinical pharmacology, pharmacokinetics and drug-drug interactions, immunopharmacology, neuropsychopharmacology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信